of Biden Administration Medicare beneficiaries would save about $1.5 billion in out-of-pocket costs on treating conditions like diabetes, heart disease and arthritis. New Price The plan is currently being negotiated with pharmaceutical companies and is expected to come into effect in 2026.
The savings range from 79% for the diabetes drug Januvia to 38% for the blood-cancer drug Imbruvica. These are the costs of the drugs before discounts and rebates are applied, not the price people actually pay when their prescriptions are filled.
Let’s look at the drugs and the negotiated prices.
Januvia
Manufacturer: Merck Sharp Dome
Medical Condition: Diabetes
Negotiated price: $113 for a 30 day supply
Reduction rate: 79%
Fiasp; Fiasp FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill:
Manufacturer: Novonolodisk
Medical Condition: Diabetes
Negotiated price: $119 for a 30 day supply
Reduction rate: 76%
Farsiga
Manufacturer: AstraZeneca AB.
Medical Conditions: Diabetes, heart failure, chronic kidney disease
Negotiated price: $178.50 for a 30 day supply
Reduction rate: 68%
Enbrel
Manufacturer: Immunex Corp.
Symptoms: Rheumatoid arthritis, psoriasis, psoriatic arthritis
Negotiated price: $2,355 for a 30-day supply
Reduction rate: 67%
Jardiance
Manufacturer: Boehringer Ingelheim
Medical Conditions: Diabetes, heart failure, chronic kidney disease
Negotiated price: $197 for a 30 day supply
Reduction rate: 66%
Stellara
Manufacturer: Janssen Biotech Inc.
Conditions: Psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis
Negotiated price: $4,695 for a 30-day supply
Reduction rate: 66%
Xarelto
Manufacturer: Janssen Farms
Symptoms: Prevention and treatment of blood clots. Risk reduction for patients with coronary artery disease or peripheral artery disease
Negotiated price: $197 for a 30 day supply
Reduction rate: 62%
Elixir
Manufacturer: Bristol-Myers Squibb
Symptoms: Preventing and Treating Blood Clots
Negotiated price: $231 for a 30-day supply
Reduction rate: 56%
Entrance
Manufacturer: Novartis Pharms Corp
Symptoms: Heart failure
Negotiated price: $295 for a 30 day supply
Reduction rate: 53%
Ibrubic
Manufacturer: Pharmacyclics LLC
Symptoms: Blood cancer
Negotiated price: $9,319 for a 30-day supply
Savings: 38%
